Magazine 14.17

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First ItalianζoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.

Date: 2021

Scope of interest: Epilepsy

You may also be interested in:

Report/Poster of Convention/Congress Act

SPES: the microeradication of HCV infection in prisons

Authors: OF the island

Date: 2018

Scope of interest: prison health

Read details

Report/Poster of Convention/Congress Act

Severe hypoglycemia is associated with the use of oral anti-diabetics compared to insulin in patients with Type 2 Diabetes Mellitus in RSA: Results of the HOME STUDY

Authors: Abbatecola A.M., Bo M., Barbagallo M., Antonelli Incalzi R., Pilotto A., Bellelli G., Maggi S., Paolisso G

Date: 2014

Scope of interest: RSA, diabetes

Read details

Magazine 9.06

Use of Plerixafor in Predicted and Proven Poor Mobilizer (according to GITMO criteria). Experience of Policlinico Universitario Tor Vergata”

Authors: Postorino M., Rossi R., Zizzari A. G., Marchesi F., Provenzano I., Franceschini L., Pupo L., Rizzo M., .Giannì L, Gumenyuk S., De Santis G., Renzi D., Guiducci G., Fiorelli E., Coniglione F., Puliti R., Berrini A., Dauri M..

Date: 2012

Scope of interest: Haematology

Read details